Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
fda
genentech
2
×
life sciences
national blog main
national top stories
roche
san francisco top stories
avapritinib
billy dunn
biogen
blueprint medicines
boston
boston blog main
boston top stories
cstone pharmaceuticals
deals
drug prices
drug pricing
eli lilly
europe top stories
european medicines agency
evrysdi
fisogatinib
flatiron health
gene therapy
hepatocellular carcinoma
investing
ionis pharmaceuticals
jeff albers
medullary thyroid cancer
national
new york top stories
non-small cell lung cancer
novartis
nusinersen
pralsetinib
risdiplam
rna drugs
What
drug
fda
2
×
roche
2
×
approval
approved
atrophy
blueprint
cancer
candidate
currently
daily
evrysdi
friday
green
home
intended
lights
liquid
marketing
medicine
medicines
muscle
muscular
new
oral
pact
patients
regulatory
ret
review
risdiplam
spinal
team
therapy
wins
Language
unset
Current search:
roche
×
genentech
×
fda
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
